Trial · NCT07912151
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in Berg Balance Scale (BBS) | Baseline (Day 0) and Day 12 | The BBS assesses static and dynamic balance with 14 items; total score ranges from 0 to 56, where higher scores indicate better balance. |
| Secondary | Change from Baseline in Berg Balance Scale (BBS) at Day 6 | Baseline (Day 0) and Day 6 | Interim BBS assessment; range 0 to 56, where higher scores indicate better balance. |
| Secondary | Change from Baseline in Functional Independence Measure (FIM) | Day 0, Day 6, Day 12 | The FIM assesses the level of assistance needed in daily activities (motor and cognitive domains); total score ranges from 18 to 126, where higher scores indicate greater independence. |
| Secondary | Change from Baseline in Morse Fall Scale (MFS) | Day 0, Day 6, Day 12 | The MFS estimates fall risk from six items; score ranges from 0 to 125, where higher scores indicate higher fall risk. |
| Secondary | Change from Baseline in Hauser Ambulation Index (HAI) | Day 0, Day 6, Day 12 | The HAI rates walking ability from 0 (fully active) to 9 (restricted to wheelchair, unable to transfer), where higher scores indicate worse mobility. |
| Secondary | Change from Baseline in modified Rankin Scale (mRS) | Day 0, Day 6, Day 12 | The mRS measures global disability and dependence; range 0 (no symptoms) to 6 (death), where higher scores indicate greater disability. |
| Secondary | Change from Baseline in Rivermead Mobility Index (RMI) | Day 0, Day 6, Day 12 | The RMI assesses functional mobility with 15 items from turning in bed to running; range 0 to 15, where higher scores indicate better mobility. |
| Secondary | Change from Baseline in National Institutes of Health Stroke Scale (NIHSS) | Day 0, Day 6, Day 12 | The NIHSS quantifies stroke-related neurological deficit; range 0 to 42, where higher scores indicate more severe deficit. |
| Secondary | Change from Baseline in Medical Research Council (MRC) Muscle Strength Score | Day 0, Day 6, Day 12 | Muscle strength of the paretic limbs graded per muscle group from 0 (no contraction) to 5 (normal strength), where higher scores indicate greater strength. |
| Secondary | Change from Baseline in Modified Ashworth Scale (MAS) | Day 0, Day 6, Day 12 | The MAS measures resistance to passive movement (spasticity) from 0 to 4, where higher scores indicate more severe spasticity. |
| Secondary | Number of Participants With Adverse Events | Day 0 through Day 12 | Adverse events related to stabilometry or tDCS (e.g., skin irritation, headache, dizziness, falls, seizures), recorded at each session. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07912151/registered